Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Rishi R. Goel(University of Pennsylvania), E. John Wherry(Parker Institute for Cancer Immunotherapy), Philip Hicks(University of Pennsylvania), Mark M. Painter(Translational Therapeutics (United States)), Christopher M. McAllister(University of Pennsylvania), Michael R. Betts(University of Pennsylvania), Jacob T. Hamilton, Eline T. Luning Prak(University of Pennsylvania), Sarah Dysinger(University of Pennsylvania), Wenzhao Meng(University of Pennsylvania), Sigrid Gouma(University of Pennsylvania), Scott E. Hensley(University of Pennsylvania), Divij Mathew(Parker Institute for Cancer Immunotherapy), Derek A. Oldridge(California University of Pennsylvania), Paul Bates(University of Pennsylvania), Aaron M. Rosenfeld(University of Pennsylvania), Sharon Adamski(United States Military Academy), Jeanette Dougherty(Translational Therapeutics (United States)), Allison R. Greenplate(California University of Pennsylvania), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Kendall A. Lundgreen(University of Pennsylvania), Scott W. Korte(University of Pennsylvania), Oliva Kuthuru(Translational Therapeutics (United States)), Amy E. Baxter(Translational Therapeutics (United States)), Amanda Hicks(University of Pennsylvania), Sherea Long(University of Pennsylvania), Leticia Kuri-Cervantes(University of Pennsylvania), Sokratis A. Apostolidis(University of Pennsylvania), Madison E. Weirick(University of Pennsylvania), Kurt D’Andrea(University of Pennsylvania), Ajinkya Pattekar(University of Pennsylvania)
Cited by 729
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
T cell responses in patients with COVID-19
|Nature reviews. Immunology|2020|873
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|801